Skip to main content

Table 1 Patient related factors and comorbidities and the prevalence of right ventricular dysfunction

From: Diagnosis and treatment of right ventricular dysfunction in patients with COVID-19 on veno-venous extra-corporeal membrane oxygenation

Demographics and PMH

Total, n = 33

No RV dysfunction, n = 19

RV dysfunction, n = 14

P value

Mean age (years) ± STDV

48.7 ± 9.2

50.4 ± 7.7

46.5 ± 10.5

 

Mean BMI ± STDV

30.2 ± 3.5

30.9 ± 3.4

29.3 ± 3.6

 

Male

72.7%

73.7%

71.4%

 

Non-White

78.8%

73.7%

85.7%

 

DM %

36.36%

42.11%

28.60%

0.109

HTN %

33.33%

42.11%

21.43%

0.0104

Smoker %

35.48%

29.41%

42.86%

0.109

Lung disease (OSA, Asthma, COPD) %

27.27%

15.79%

42.86%

0.0002